Victory Capital Management Inc Plus Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.43 - $2.33 $925 - $1,507	-647 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.05 - $2.85 $14 - $39	-14 Reduced 2.12%	647 $1,000
Q4 2019 Feb 04, 2020	BUY	$1.99 - $3.23 $1,152 - $1,870	579 Added 706.1%	661 $1,000
Q3 2019 Nov 12, 2019	BUY	$3.3 - $19.25 $270 - $1,578	82 New	82 $0

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $41.3M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.